From all of us here at TestAVec, we wish you a happy holiday season and new year. Time to enjoy the festive period and go into 2024 to...

TestAVec and Vidiia are working together to accelerate DiNARep to commercial testing. DiNARep identifies if patients are able to repair...

Recently, the US Food and Drug Administration (FDA) has expressed that it is investigating cases of blood cancer in CAR-T therapies....

Better results for patients on chemotherapy, radiotherapy and gene therapy A personalised test that tells how well chemotherapy,...

TestAVec's hInGeTox saftey assay has been awarded a patent from Japan. Two of TestAVec's key saftey tests, hInGeTox and DiNARep, have now...